Skip to main content
SpringerLink
Log in

Treatment options for low-risk prostate cancer

  • Letter to the Editor
  • Published:
World Journal of Urology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Liang Z, Zhou Z, Yang S et al (2021) Can patients with low-risk prostate cancer really benefit from radical treatment?: a systematic review and network meta-analysis. Andrologia 53:e14122. https://doi.org/10.1111/and.14122

    Article  Google Scholar 

  2. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.

  3. Hayashi N, Osaka K, Muraoka K et al. (2020) Outcomes of treatment for localized prostate cancer in a single institution: comparison of radical prostatectomy and radiation therapy by propensity score matching analysis. World J Urol 38: 2477-2484. doi: https://doi.org/10.1007/s00345-019-03056-3

  4. Giberti C, Chiono L, Gallo F et al. (2009) Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective study. World J Urol 27: 607–612. doi:https://doi.org/10.1007/s00345-009-0418-9

  5. Hamdy FC, Donovan JL, Lane JA et al. (2016) 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. New Engl J Med 375: 1415–1424. doi:https://doi.org/10.1056/NEJMoa1606220

  6. Freedland SJ, Hotaling JM, Fitzsimons NJ et al. (2008) PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes-results from the search database. Eur Urol 53: 758–764. doi:https://doi.org/10.1016/j.eururo.2007.08.047

  7. Doi SAR, Barendregt JJ, Khan S et al. (2015) Advances in the meta-analysis of heterogeneous clinical trials i: the inverse variance heterogeneity model. Contemp Clin Trials 45: 130–138. doi:https://doi.org/10.1016/j.cct.2015.05.009

  8. Hirama H, Sugimoto M, Miyatake N et al. (2021) Health-related quality of life in japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN. World J Urol 39: 2491–2497. doi:https://doi.org/10.1007/s00345-020-03494-4

Download references

Funding

This study was supported by National Key Research and Development Program of China (2018YFA0902802) and The Capital Health Research and Development of Special (2022-4-4087).

Author information

Authors and Affiliations

  1. Department of Urology, Peking University People’s Hospital, Beijing, 100044, China

    Yuxuan Song & Tao Xu

Authors
  1. Yuxuan Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tao Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Y. S. Project development, literature collection and manuscript writing. T. X. Project development and manuscript writing.

Corresponding author

Correspondence to Tao Xu.

Ethics declarations

Conflicts of interest

None.

Ethical approval

Not applicable.

Informed consent

All the authors consent for the publication of the article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Song, Y., Xu, T. Treatment options for low-risk prostate cancer. World J Urol 40, 2827–2828 (2022). https://doi.org/10.1007/s00345-022-04144-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-022-04144-7

Search

Navigation